John Ferraro

Dr. John Ferraro


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2006 in Journal of the American Academy of Audiology
Verified
Journal Article
Closed access
JFJohn Ferraro
John Ferraro
JDJohn D. Durrant
John D. Durrant
Electrocochleography (ECochG) has evolved as an important tool in the diagnosis/assessment/monitoring of Ménière's disease/endolymphatic hydrops (MD/ELH). This manuscript provides an update on the use of ECochG for these purposes. The material presented includes descriptions of the components of the electrocochleogram; ECochG recording approaches and parameters; how to prepare for an exam, including subject/patient considerations; construction and placement of a tympanic membrane recording electrode; and interpretation the electrocochleogram. Various approaches aimed at improving ECochG's sensitivity and specificity to MD/ELH also are described. These approaches go beyond simple measurement of the now-conventional summating potential (SP)/action potential (AP) magnitude ratio to include the SP magnitude to tonebursts, the SP/AP area ratio, and the AP latency difference to clicks of opposing polarity. Spanish La electrococleografía (ECochG) ha evolucionado como una importante herramienta en el diagnóstico, evaluación y monitoreo de la enfermedad de Ménière-hydrops endolinfático (MD/HEL). Este manuscrito aporta una actualización en el uso de la ECochG para estos propósitos. El material presentado incluye descripción de los componentes del electrococleograma; parámetros y enfoques de registro del ECochG; cómo prepararse para un examen, incluyendo consideraciones para el sujeto/paciente; construcción y colocación de un electrodo de registro en la membrana timpánica, e interpretación del electrococleograma. Se describen también varios enfoques orientados a mejorar la sensibilidad y la especificidad de la ECochG en la MD/HEL. Estos enfoques van más allá de la simple medición de la convencional tasa de magnitud del potencia de suma (SP)/potencial de acción (AP), e incluyen la magnitud del SP para bursts tonales, la tasa de área de SP/AP y la diferencia de latencia del AP a clics de polaridad opuesta.

1 June 1999 in American Journal of Audiology
Verified
Journal Article
Closed access
PDF file
JFJohn Ferraro
John Ferraro
RTRichard P. Tibbils
Richard P. Tibbils
Conventional analysis of the click-evoked electrocochleogram includes measurement of the amplitudes of the cochlear summating potential (SP) and auditory nerve action potential (AP) to derive the SP/AP amplitude ratio. It is now well documented that an amplitude ratio where SP is elevated relative to AP may be a positive finding for endolymphatic hydrops in patients suspected of having Meniere's disease (MD). However, the incidence of an elevated SP/AP amplitude ratio in the general MD population is only ≈60%. This relatively low value necessitates efforts to improve the diagnostic sensitivity of electrocochleography (ECochG) for MD. A review of early and more recent literature in this area indicates that consideration of both the amplitude and duration of ECochG components may help to achieve this goal. The present study combined these features to measure the "area" of the SPAP complex in normal and MD populations. A software routine was used to measure the amplitude x duration area of the SP-AP complex in (a) normally hearing adults with normal SP/AP amplitude ratios (Group 1), (b) confirmed MD patients with elevated SP/AP amplitude ratios (Group 2), and (c) probable MD patients with normal SP/AP amplitude ratios (Group 3). Ninety percent of the confirmed MD patients in Group 2 displayed elevated SP/AP area ratios relative to the normative value established from Group 1. In addition, almost half of the probable MD patients from Group 3 displayed elevated area ratios. These findings indicate that measurement of the SP/AP area ratio holds promise for improving the sensitivity of ECochG in the diagnosis of MD.

1 March 2010 in Journal of the American Academy of Audiology
Verified
Journal Article
Closed access
JFJohn Ferraro
John Ferraro
Research related to expanding and improving the clinical use of electrocochleography (ECochG) has been ongoing for 25 yr at the University of Kansas Medical Center. This article presents highlights of findings from our laboratory during this period that have contributed to current ECochG recording approaches and clinical applications. A review of new data related to improving the sensitivity of ECochG in the diagnosis of Ménière's disease, the use of an ear canal recording approach for improving auditory brain stem response testing in newborns, and technical aspects related to recording the cochlear microphonic in newborns also will be presented.

1 January 1997 in Audiology and Neurotology
Verified
Journal Article
Closed access
PDF file
JFJohn Ferraro
John Ferraro
GKGeetha Krishnan
Geetha Krishnan
The recording of cochlear and auditory nerve potentials in humans via Electrocochleography (ECochG) has emerged as a valuable tool for a variety of clinical applications. This review consolidates current research on the use of cochlear potentials Ménière’s disease/ and ECochG in the clinical setting and identifies several areas in need of additional study. Methodological topics discussed include a review of ECochG recording approaches (i.e. trans-tympanic versus extratympanic) and issues related to choice of stimuli (clicks versus tonebursts). The review of current applications for cochlear potentials focuses primarily on the use of ECochG in the identification and treatment of Ménière’s disease/endolymphatic hydrops (MD/ELH). Other uses for ECochG also are presented (e.g. intraoperative monitoring, enhancement of ABR wave I, estimation of hearing sensitivity). Several suggestions are offered to maximize the predictive value of ECochG in the diagnosis of MD/ELH.

1 June 2017 in Journal of Otology
Verified
Journal Article
Open access
SGSigne Schuster Grasel
Signe Schuster Grasel
RBRoberto Miquelino de Oliveira Beck
Roberto Miquelino de Oliveira Beck
RLRicardo Silva Chiabai Loureiro
Ricardo Silva Chiabai Loureiro
ARAmanda Costa Rossi
Amanda Costa Rossi
EAEdigar Rezende de Almeida
Edigar Rezende de Almeida
JFJohn Ferraro
John Ferraro
Establish normative data for tympanic electrocochleography (TM ECochG) parameters in normal hearing adults without Ménière's disease's (MD) symptoms. Describe TM ECochG variables that help to distinguish normal from MD ears. We enrolled 100 subjects (N = 200 ears), 59 females, aged between 19 and 71 years from 09/2010 to 04/2014. Inclusion criteria: normal otomicroscopy, hearing thresholds ≤25 dB nHL from 250 to 4000 Hz, normal tympanogram, no symptoms of MD according to the AAO-HNS 1995 criteria and Gibson's score <7. We excluded subjects with dizziness, aural fullness or other symptoms of endolymphatic hydrops. The following parameters were analyzed: SP/AP amplitude ratio, SP/AP area ratio and the difference between AP latency with rarefaction and condensation stimuli. There was no significant difference between right and left ears (Intraclass correlation coefficient < 0.6). SP/AP amplitude ratio varied between 0.084 and 0.356 and SP/AP area ratio between 0.837 and 1.671 (percentiles 5 and 95). The AP latency difference to rarefaction and condensation clicks was between 0.0 and 0.333 ms. Normative data for TM ECochG parameters were established in 100 normal hearing subjects without MD. These data can be used to distinguish normal from pathological findings and in follow-up of MD patients.

1 April 2020 in Hearing Research
Verified
Journal Article
Closed access
AJAbdullah M. Jamos
Abdullah M. Jamos
WKWafaa A. Kaf
Wafaa A. Kaf
MCMark E. Chertoff
Mark E. Chertoff
JFJohn Ferraro
John Ferraro